January 19, 2022
January 14, 2022
January 12, 2022
January 12, 2022
January 20, 2022
January 20, 2022
January 4, 2022
First approved in late 2016, Spinraza has become one of the most important medicines in Biogen’s arsenal, accounting for about a fifth of the company’s total product revenue. Recently, though, the Spinraza franchise hasn’t fared as well due to competitive […]
December 28, 2021
Anton Middelberg, PhD, deputy vice-chancellor and vice-president of research at the University of Adelaide in Australia, believes industry reluctance to go continuous reflects the traditional focus on batch-mode production and, in some areas, the technical challenges. “The complexity in continuous […]
December 22, 2021
The data are clear: White patients are taking up the majority of clinical trials. About 130 million Americans across various races are “being somewhat ignored, [or] deprioritized, in clinical trials” that support regulatory approval, said Yele Aluko, M.D., chief medical […]
January 19, 2022
European Pharmaceutical ReviewAccording to the European Medicines Agency (EMA)’s COVID-19 task force (ETF), a growing body of evidence suggests that messenger RNA (mRNA) COVID-19 vaccines do not cause pregnancy complications for expectant mothers and their babies. The ETF undertook a detailed review […]
January 19, 2022
Drugs.comIf COVID-19 vaccines and medicines are shared equally worldwide, the pandemic could ease this year, a top World Health Organization official said Tuesday. However, if wealthier countries don’t share their resources with poorer countries, there will continue to be high […]
Manufacturing, Research and Development
January 18, 2022
FiercePharmaOri Biotech, which is on the cusp of launching an innovative process for manufacturing cell and gene therapies (CGTs), tallied more than $100 million in its latest funding round. The company will use the money to add key personnel in […]
Manufacturing, Research and Development
January 18, 2022
FiercePharmaStanford University spinout N1 Life has formed a joint venture to further its drug delivery ambitions. The startup is teaming up with Accuredit Therapeutics to create a joint venture, Napoltec, focused on novel drug delivery systems and the progression of […]
January 18, 2022
Biopharma DiveDeveloping drugs is a capital-intensive activity, and never more so than when a biotech company wants to move from preclinical development to more expensive clinical trials. Early on, there are often angel investments and/or academic or government grants, but the […]
Manufacturing, Research and Development
January 18, 2022
Biopharm InternationalSamsung Biologics announced on Jan. 12, 2022 that it plans to start building a new facility (designated Plant 5) at Songdo in Incheon, South Korea, this year. The facility will offer manufacturing for multi-modal products, including cell and gene therapies […]
January 20, 2022
January 20, 2022
December 30, 2021
December 28, 2021
January 4, 2022
Copyright © 2022. All rights reserved
